GUARDANT HEALTH Earnings Estimate
GUARDANT HEALTH Earnings per Share Projection vs Actual
About GUARDANT HEALTH Earnings Estimate
The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of GUARDANT HEALTH earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current GUARDANT HEALTH estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as GUARDANT HEALTH fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. Guardant Health, Inc. was incorporated in 2011 and is headquartered in Redwood City, California. GUARDANT HEALTH operates under Diagnostics Research classification in Germany and is traded on Frankfurt Stock Exchange. It employs 864 people.
Currently Active Assets on Macroaxis
Other Information on Investing in GUARDANT Stock
GUARDANT HEALTH financial ratios help investors to determine whether GUARDANT Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in GUARDANT with respect to the benefits of owning GUARDANT HEALTH security.